Please use this identifier to cite or link to this item:
Title: Biopsychosocial and clinical characteristics in patients with resected breast and colon cancer at the beginning and end of adjuvant treatment
Author: García-García, Teresa
Carmona-Bayonas, Alberto
Jiménez Fonseca, Paula
Jara, Carlos
Beato, Carmen
Castelo, Beatriz
Mangas-Izquierdo, Montserrat
Martínez de Castro, Eva
Ramchandani, Avinash
Gómez, David
Calderón Garrido, Caterina
Keywords: Càncer de mama
Breast cancer
Issue Date: 1-Nov-2019
Publisher: BioMed Central
Abstract: Background The aim of this study was to analyze biopsychosocial factors affecting how patients cope with cancer and adjuvant treatment and to appraise psychological distress, coping, perceived social support, quality of life and SDM before and after adjuvant treatment in breast cancer patients compared to colon cancer patients. Methods NEOcoping is a national, multicenter, cross-sectional, prospective study. The sample comprised 266 patients with colon cancer and 231 with breast cancer. The instruments used were the Brief Symptom Inventory (BSI), Mini-Mental Adjustment to Cancer (Mini-MAC), Multidimensional Scale of Perceived Social Support (MSPSS), Shared Decision-Making Questionnaire-Patient (SDM-Q-9) and Physician's (SDM-Q-Doc), and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ). Results Breast cancer patients reacted worse to the diagnosis of cancer with more symptoms of anxiety, depression, and somatization, and were less satisfied with their involvement than those with colon cancer (p = 0.003). Participants with colon cancer were older and had more physical symptoms and functional limitations at the beginning of adjuvant treatment, while there were scarcely any differences between the two groups at the end of adjuvancy, at which time both groups suffered greater psychological and physical effects and scored lower on coping strategies, except for anxious preoccupation. Conclusions Breast cancer patients need more information and involvement of the oncologist in shared decision-making, as well as and more medical and psychological support when beginning adjuvant treatment. Both breast and colon cancer patients may require additional psychological care at the end of adjuvancy.
Note: Reproducció del document publicat a:
It is part of: BMC Cancer, 2019, vol. 19, p. 1143
Related resource:
ISSN: 1471-2407
Appears in Collections:Articles publicats en revistes (Psicologia Clínica i Psicobiologia)

Files in This Item:
File Description SizeFormat 
693907.pdf923.81 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons